Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vivaglobin in previously untreated primary immunodeficiency
NCT00520494Phase 4Completed
- Sponsor
- CSL Limited
- Start
- Mar 2007
- Primary completion
- Oct 2008
- Modality
- Biologic
- Countries
- 4
01
Overview
A Phase 4 trial of IgPro10 in primary immunodeficiency (PI), sponsored by CSL Limited. Started Mar 2007; status: completed.
02
Drugs
IgPro10
03
Conditions
primary immunodeficiency (PI)
Beyond the preview
Go deeper on NCT00520494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00520494.